Evaluation of childhood hospitalization rates and degree of severity of SARS‐CoV‐2 variants, including B.1.1.7 (Alpha), B.1.315/P.1 (Beta/Gamma), and B.1.617.2 (Delta)

Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK

(2021) Julian W. Tang et al.   JOURNAL OF INFECTION

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021

(2021) Tjede Funk et al.   Eurosurveillance

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

(2021) Aziz Sheikh et al.   LANCET

Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study

(2021) Martina Patone et al.   LANCET INFECTIOUS DISEASES

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

(2021) Katherine A Twohig et al.   LANCET INFECTIOUS DISEASES

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

(2020) Bette Korber et al.   CELL

Clinical Manifestations and Outcomes of Critically Ill Children and Adolescents with COVID-19 in New York City

(2020) Kim R. Derespina et al.   JOURNAL OF PEDIATRICS

Mechanisms of SARS-CoV-2 transmission and pathogenesis

(2020) Andrew G. Harrison et al.   TRENDS IN IMMUNOLOGY

Emergence of a new SARS-CoV-2 variant in the UK

(2020) Julian W Tang et al.   JOURNAL OF INFECTION

Covid-19: New coronavirus variant is identified in UK

(2020) Jacqui Wise   BMJ-British Medical Journal